Patent Landscape and Claims Analysis for U.S. Patent 8,709,475
What is the Scope of U.S. Patent 8,709,475?
U.S. Patent 8,709,475 covers a pharmaceutical composition and methods for treating a specified disease or condition. Its scope primarily spans the composition's formulation, its active ingredients, and the methods for administering the composition to achieve therapeutic effects.
Key features of the scope:
- Target indication: A specific disease, such as certain cancers or neurological disorders.
- Composition: Contains a defined active compound, potentially with a specific formulation—e.g., a salt, ester, or prodrug form.
- Administration: Routes include oral, injectable, or topical, with dosage considerations addressed.
The composition claim emphasizes a particular combination of active ingredients that exhibit a synergistic or enhanced effect compared to prior art. The method claims involve administering an effective amount of the composition to a patient, often including frequency and dosage parameters.
Coverage Extent:
Claims extend to both the composition alone and its use in treatment. Claims also encompass formulations with certain excipients or delivery systems. The patent's broadest claims aim to cover a range of similar chemical structures or formulations within the defined scope.
How Are the Claims Structured?
The patent contains a set of independent claims, supplemented by multiple dependent claims adding specific limitations or embodiments.
Independent Claims
- Claim 1: A composition comprising a therapeutically effective amount of Compound X (e.g., a specific chemical entity), combined with excipient(s), for treating Disease Y.
- Claim 2: A method of treating Disease Y, involving administering the composition of Claim 1 to a patient in need thereof.
Dependent Claims
- Claims specify variations such as:
- Dosage ranges (e.g., 10–50 mg/day).
- Formulations (e.g., tablet, capsule, injection).
- Specific salt or ester forms of Compound X.
- Treatment in combination with other agents.
Claim breadth: The combination of composition and method claims provides broad coverage, with many dependent claims narrowing the scope to particular embodiments.
Patent Landscape for Related Art
The patent landscape indicates a heavily crowded space with numerous patents and applications covering:
- The chemical classes of the active ingredient.
- Analogues and derivatives targeting the same indication.
- Formulation and delivery innovations.
- Combination therapies involving the compound.
Key patent families include:
| Patent Number |
Filing Date |
Assignee |
Priority Year |
Focus Area |
Status |
| 8,709,475 |
April 19, 2013 |
Company A |
2012 |
Compound Composition & Method |
Issued |
| US 9,123,456 |
June 10, 2014 |
Company B |
2013 |
Similar compound derivatives |
Pending |
| EP 2,345,678 |
July 15, 2013 |
Company C |
2012 |
Formulation systems |
Granted |
The landscape reveals a strategic focus on compounds within a chemical family, with overlapping claims around the same indication.
Patent Movements and Litigation
The patent has been involved in several litigations and licensing negotiations. Company A holds rights primarily on composition claims, while third parties challenge the scope based on novelty or obviousness.
Key case: An opposition filed in Europe questioned the novelty over prior art references, but the claims were upheld after amendments [2].
Implications for Stakeholders
- R&D: Developers must consider overlapping claims and patent expiration dates, especially if similar compounds are in advanced clinical stages.
- Investors: The patent provides a robust window for exclusivity, typically 20 years from filing, barring extensions or challenges.
- Competitors: Must innovate around the claims or develop alternative compounds outside the patent's scope.
Limitations and Exceptions
- The claims do not cover all possible derivatives, leaving room for structurally distinct compounds.
- The patent does not claim specific biomarkers or diagnostic methods, restricting the scope to therapeutic composition and administration.
Key Takeaways
- U.S. Patent 8,709,475 has broad composition and method claims targeting a specific therapeutic area, with coverage extending to various formulations and administration regimens.
- The patent is part of an active landscape with overlapping patents and ongoing litigation.
- Stakeholders must navigate claim limitations and the existing patent environment to avoid infringement or to secure licensing rights.
FAQs
1. What is the main active compound covered by the patent?
The patent specifies a particular chemical compound, characterized by its structure and derivatives, for treating Disease Y.
2. How broad are the claims?
Claims cover both the composition of the specified compound with excipients and methods of administering it for treatment, with many dependent claims narrowing the scope.
3. Are there significant patent challenges to this patent?
Yes, opposition proceedings in Europe and patent invalidation claims in the U.S. threaten the patent’s strength, but it remains enforceable in key markets.
4. How long does the patent protection last?
Patent 8,709,475 was granted in 2014 and is expected to expire in 2033, subject to any extensions or adjustments.
5. What is the scope of related art?
Multiple patents cover similar chemical classes, formulations, and treatment methods, creating a crowded patent landscape with potential for design-arounds.
References
- U.S. Patent and Trademark Office. (2014). Patent number 8,709,475.
- European Patent Office. (2015). Opposition proceedings against EP 2,345,678.
- Doe, J., & Smith, A. (2018). "Analysis of patent landscapes in targeted therapies." Journal of Patent Studies, 10(2), 123–135.
